TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against MoonLake Immunotherapeutics alleging false statements about its drug candidate sonelokimab, with claims of misrepresenting drug efficacy leading to significant stock value loss.

Insights
MLTX   negative

The lawsuit alleges the company made materially false statements about its drug candidate, misrepresented its efficacy, and caused investors to suffer significant financial losses when the stock dropped nearly 90% after revealing trial results